Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 21,535 clinical trials worldwide
Search
Showing 16251-16300 of 21,535 trials
Active filters:
Status: Active, not recruiting
Clinical Trials (21,535)
NCT03758417
A Study of LCAR-B38M CAR-T Cells, a Chimeric Antigen Receptor T-cell (CAR-T) Therapy Directed Against B-cell Maturation Antigen (BCMA) in Chinese Participants With Relapsed or Refractory Multiple Myeloma
PHASE2
Active, not recruiting
123 participants
Started: Jan 23, 2019 · Completed: Oct 20, 2025
1 condition
2 sponsors
11 locations
NCT03793127
Brown Adipose Tissue Pilot
N/A
Active, not recruiting
24 participants
Started: Jan 23, 2019 · Completed: Dec 31, 2025
1 condition
1 sponsor
1 location
NCT03168971
Managing Anxiety From Cancer (MAC): Testing an Intervention for Anxiety in Older Adults With Cancer and Their Caregivers
NA
Active, not recruiting
26 participants
Started: Jan 23, 2019 · Completed: Jan 21, 2026
3 conditions
3 sponsors
1 location
NCT03484078
Effect of Vibration on Muscle Properties, Physical Activity and Balance in Children with Cerebral Palsy
NA
Active, not recruiting
44 participants
Started: Jan 23, 2019 · Completed: Jan 30, 2026
1 condition
2 sponsors
1 location
NCT03827343
Retrospective Study of Immunotherapy Related Toxicities and Factors Impacting Outcomes in Children and Adults With Cancer
N/A
Active, not recruiting
500 participants
Started: Jan 23, 2019 · Completed: Dec 31, 2025
2 conditions
1 sponsor
1 location
NCT06347809
DNA Methylation in Adenocarcinoma of the Prostate: Analysis of Validated Biomarkers in Urine
N/A
Active, not recruiting
300 participants
Started: Jan 23, 2019 · Completed: Feb 1, 2029
2 conditions
1 sponsor
1 location
NCT03805048
PeRcutaneous cOronary Intervention of Native Coronary arTery Versus Venous Bypass Graft in Patients With Prior CABG
NA
Active, not recruiting
221 participants
Started: Jan 22, 2019 · Completed: Jun 30, 2028
1 condition
1 sponsor
21 locations
NCT03719859
Home Exercise vs PT for Reverse Total Shoulder Arthroplasty
NA
Active, not recruiting
200 participants
Started: Jan 22, 2019 · Completed: Jul 31, 2026
2 conditions
2 sponsors
7 locations
NCT03703167
Ibrutinib With Rituximab and Lenalidomide for Patients With Recurrent/Refractory Primary or Secondary Central Nervous System Lymphoma (PCNSL/SCNSL)
PHASE1
Active, not recruiting
25 participants
Started: Jan 22, 2019 · Completed: Nov 30, 2025
2 conditions
2 sponsors
7 locations
NCT03839498
Study of Axitinib (AG-013736) With Evaluation of the VEGF-pathway in Pheochromocytoma/Paraganglioma
PHASE2
Active, not recruiting
6 participants
Started: Jan 22, 2019 · Completed: Feb 28, 2026
2 conditions
2 sponsors
1 location
NCT03912987
TRIAL READY (Clinical Trial Readiness)
N/A
Active, not recruiting
610 participants
Started: Jan 22, 2019 · Completed: Jun 30, 2026
5 conditions
3 sponsors
3 locations
NCT03406611
Pegtibatinase As an Enzyme Therapy for Patients with Homocystinuria Caused by Cystathionine Beta-Synthase Deficiency (COMPOSE)
PHASE1/PHASE2
Active, not recruiting
32 participants
Started: Jan 22, 2019 · Completed: Dec 31, 2026
1 condition
1 sponsor
8 locations
NCT03671811
Megestrol Acetate With or Without Pterostilbene in Treating Patients With Endometrial Cancer Undergoing Hysterectomy
PHASE2
Active, not recruiting
44 participants
Started: Jan 21, 2019 · Completed: Mar 30, 2026
2 conditions
2 sponsors
1 location
NCT03710876
Efficacy & Safety of rAd-IFN Administered With Celecoxib & Gemcitabine in Patients With Malignant Pleural Mesothelioma
PHASE3
Active, not recruiting
53 participants
Started: Jan 21, 2019 · Completed: Apr 30, 2026
1 condition
2 sponsors
29 locations
NCT03837483
A Clinical Study to Evaluate the Use of a Cryopreserved Formulation of OTL-103 in Subjects With Wiskott-Aldrich Syndrome
PHASE3
Active, not recruiting
10 participants
Started: Jan 21, 2019 · Completed: Sep 30, 2027
1 condition
2 sponsors
2 locations
NCT03813615
Study of the Effects of Pre-surgical Aerobic Exercise on Patients With Solid Tumors
EARLY_PHASE1
Active, not recruiting
60 participants
Started: Jan 21, 2019 · Completed: Jan 31, 2026
2 conditions
2 sponsors
8 locations
NCT03747627
BPF Genetics of ILD Study
N/A
Active, not recruiting
475 participants
Started: Jan 19, 2019 · Completed: Jan 1, 2028
6 conditions
6 sponsors
2 locations
NCT03891732
MRI Prostate for Chinese Men Being Screened for Prostate Cancer
N/A
Active, not recruiting
690 participants
Started: Jan 19, 2019 · Completed: Dec 31, 2024
3 conditions
1 sponsor
2 locations
NCT03734653
Testosterone Therapy in Castration Resistant Prostate Cancer
EARLY_PHASE1
Active, not recruiting
30 participants
Started: Jan 18, 2019 · Completed: Aug 31, 2025
2 conditions
2 sponsors
1 location
NCT03825289
Trametinib and Hydroxychloroquine in Treating Patients With Pancreatic Cancer
PHASE1
Active, not recruiting
25 participants
Started: Jan 18, 2019 · Completed: Mar 31, 2029
7 conditions
2 sponsors
2 locations
NCT03946618
Neurophysiologically Based Brain State Tracking and Modulation in Focal Epilepsy
NA
Active, not recruiting
5 participants
Started: Jan 18, 2019 · Completed: Feb 28, 2027
1 condition
3 sponsors
1 location
NCT03878407
Identification of Patients With Age-Related Clonal Hematopoiesis (ARCH) Among Cancer Survivors
N/A
Active, not recruiting
2,400 participants
Started: Jan 18, 2019 · Completed: Dec 31, 2029
1 condition
1 sponsor
1 location
NCT03598257
Radiation Therapy With or Without Olaparib in Treating Patients With Inflammatory Breast Cancer
PHASE2
Active, not recruiting
300 participants
Started: Jan 18, 2019 · Completed: Jun 1, 2027
1 condition
1 sponsor
220 locations
NCT03853356
Evidence For Fusion In Spine With Orthoss®
N/A
Active, not recruiting
65 participants
Started: Jan 18, 2019 · Completed: Jan 31, 2027
4 conditions
1 sponsor
3 locations
NCT03810807
Study of Dacomitinib and Osimertinib for Patients With Advanced EGFR Mutant Lung Cancer
PHASE1
Active, not recruiting
22 participants
Started: Jan 17, 2019 · Completed: Jan 31, 2026
1 condition
1 sponsor
7 locations
NCT03428373
Rivaroxaban or Aspirin As Thromboprophylaxis in Multiple Myeloma
PHASE2/PHASE3
Active, not recruiting
57 participants
Started: Jan 17, 2019 · Completed: Sep 30, 2024
6 conditions
5 sponsors
1 location
NCT03809715
"Coroflex ISAR NEO All Comers Post Market Clinical Follow-up (PMCF)"
N/A
Active, not recruiting
3,520 participants
Started: Jan 17, 2019 · Completed: Aug 31, 2025
1 condition
1 sponsor
1 location
NCT03375788
Growth Hormone Releasing Hormone Analog to Improve Nonalcoholic Fatty Liver Disease and Associated Cardiovascular Risk
PHASE2
Active, not recruiting
76 participants
Started: Jan 17, 2019 · Completed: Jan 10, 2025
5 conditions
1 sponsor
1 location
NCT04644224
Parent and Family Oriented Support Interventions for the Facilitation of Weight Loss in African American Families
NA
Active, not recruiting
81 participants
Started: Jan 17, 2019 · Completed: Dec 31, 2028
1 condition
1 sponsor
1 location
NCT03763162
Daratumumab, Bortezomib, and Dexamethasone Followed by Daratumumab, Ixazomib, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma
PHASE2
Active, not recruiting
40 participants
Started: Jan 17, 2019 · Completed: Oct 30, 2025
2 conditions
2 sponsors
1 location
NCT03799835
Atezolizumab Plus One-year BCG Bladder Instillation in BCG-naive High-risk Non-muscle Invasive Bladder Cancer Patients
PHASE3
Active, not recruiting
517 participants
Started: Jan 17, 2019 · Completed: Oct 31, 2028
1 condition
2 sponsors
38 locations
NCT03808662
Randomized Study of Stereotactic Body Radiation Therapy (SBRT) in Patients With Oligoprogressive Metastatic Cancers of the Breast and Lung
PHASE2
Active, not recruiting
107 participants
Started: Jan 16, 2019 · Completed: Jan 31, 2026
7 conditions
1 sponsor
10 locations
NCT03771859
A Study of Patients Receiving Adjuvant Nivolumab Therapy for Melanoma That Has Been Removed
N/A
Active, not recruiting
152 participants
Started: Jan 16, 2019 · Completed: Dec 30, 2025
1 condition
1 sponsor
14 locations
NCT04541693
REDAPT Revision Hip System With RSA
NA
Active, not recruiting
8 participants
Started: Jan 15, 2019 · Completed: Dec 31, 2027
1 condition
1 sponsor
1 location
NCT03758521
Natural History Study of Patients with Succinic Semialdehyde Dehydrogenase (SSADH) Deficiency
N/A
Active, not recruiting
55 participants
Started: Jan 15, 2019 · Completed: Jun 30, 2029
1 condition
5 sponsors
4 locations
NCT03183895
Evaluate the Safety and Performance of the AccuCinch® Ventricular Repair System - The CorCinch-EU Study
NA
Active, not recruiting
132 participants
Started: Jan 15, 2019 · Completed: Dec 31, 2027
2 conditions
1 sponsor
19 locations
NCT03865667
Post Market Clinical Follow-Up Study Protocol for PROFEMUR® Preserve Femoral Stem
N/A
Active, not recruiting
63 participants
Started: Jan 15, 2019 · Completed: Jan 1, 2032
1 condition
1 sponsor
1 location
NCT03756298
Efficacy and Safety of Atezolizumab Plus Capecitabine Adjuvant Therapy for Triple Receptor-Negative Breast Cancer
PHASE2
Active, not recruiting
284 participants
Started: Jan 15, 2019 · Completed: Jan 31, 2027
1 condition
1 sponsor
1 location
NCT03385226
A Trial Assessing the Effect of Pembrolizumab Combined with Radiotherapy in Patients with Relapsed, Refractory, Specified Stages of Cutaneous T-cell Lymphoma (CTCL) Mycosis Fungoides (MF)/Sezary Syndrome (SS)
PHASE2
Active, not recruiting
46 participants
Started: Jan 15, 2019 · Completed: Sep 30, 2025
2 conditions
2 sponsors
11 locations
NCT03785249
Phase 1/2 Study of MRTX849 in Patients With Cancer Having a KRAS G12C Mutation KRYSTAL-1
PHASE1/PHASE2
Active, not recruiting
731 participants
Started: Jan 15, 2019 · Completed: Dec 31, 2026
3 conditions
1 sponsor
222 locations
NCT03783546
Acupuncture for Hot Flashes in Hormone Receptor-Positive Breast Cancer, a Randomized Controlled Trial
NA
Active, not recruiting
84 participants
Started: Jan 15, 2019 · Completed: Dec 1, 2025
1 condition
2 sponsors
1 location
NCT03812666
Search for Biomarkers of Infection and Inflammation in Patients With Acute Stroke.
N/A
Active, not recruiting
200 participants
Started: Jan 15, 2019 · Completed: Jul 1, 2025
2 conditions
2 sponsors
1 location
NCT03266393
Envarsus XR® in Adolescent Renal Transplant Recipients
PHASE4
Active, not recruiting
28 participants
Started: Jan 15, 2019 · Completed: Mar 31, 2023
3 conditions
2 sponsors
1 location
NCT02573896
Immunotherapy of Relapsed Refractory Neuroblastoma With Expanded NK Cells
PHASE1
Active, not recruiting
13 participants
Started: Jan 14, 2019 · Completed: Sep 30, 2025
1 condition
3 sponsors
11 locations
NCT03808077
The Effect of Deep Versus Moderate Muscle Relaxants in Men During and After Robotic Surgery for Prostate Cancer
PHASE2
Active, not recruiting
139 participants
Started: Jan 14, 2019 · Completed: Jan 31, 2026
1 condition
1 sponsor
1 location
NCT03672318
Study of ATLCAR.CD138 Cells for Relapsed/Refractory Multiple Myeloma
PHASE1
Active, not recruiting
25 participants
Started: Jan 14, 2019 · Completed: Aug 18, 2039
2 conditions
2 sponsors
1 location
NCT03854110
Trial to Evaluate Safety and Tolerability of GP-2250 in Combination With Gemcitabine
PHASE1
Active, not recruiting
64 participants
Started: Jan 14, 2019 · Completed: Jun 30, 2026
1 condition
2 sponsors
5 locations
NCT03732898
Coordinated Reset Deep Brain Stimulation
NA
Active, not recruiting
15 participants
Started: Jan 13, 2019 · Completed: Nov 30, 2025
1 condition
1 sponsor
2 locations
NCT03792061
Enhancing Community Participation for Stroke Survivors With Cognitive Impairments
NA
Active, not recruiting
210 participants
Started: Jan 13, 2019 · Completed: Dec 31, 2024
2 conditions
1 sponsor
4 locations
NCT03562728
Progressive Rehabilitation Therapy in Patients With Advanced Lung Disease
NA
Active, not recruiting
70 participants
Started: Jan 13, 2019 · Completed: Nov 1, 2027
3 conditions
1 sponsor
1 location
Previous
1
More pages
323
324
325
326
327
328
329
More pages
431
Next